A multicenter, randomized, double blind, double dummy, parallel group study to compare effects of Coreg CR [carvedilol controlled release] and Coreg IR [carvedilol immediate release] on ejection fraction in subjects with stable chronic heart failure
Phase of Trial: Phase III
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Carvedilol (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms COMPARE
- 31 Aug 2018 Biomarkers information updated
- 11 Jan 2008 The expected completion date for this trial is now 1 Apr 2008.
- 07 Aug 2007 Status changed from recruiting to in progress.